Terbutaline sulfate and Staring - a phase IV clinical study of FDA data

Summary:

Staring is reported as a side effect among people who take Terbutaline sulfate (terbutaline sulfate), especially for people who are female, also take Hydroxyzine Pamoate, and have Depression.

The phase IV clinical study analyzes which people have Staring when taking Terbutaline sulfate. It is created by eHealthMe based on reports of 2,731 people who have side effects when taking Terbutaline sulfate from the FDA, and is updated regularly.

What is Terbutaline sulfate?

Terbutaline sulfate has active ingredients of terbutaline sulfate. It is often used in asthma. eHealthMe is studying from 2,777 Terbutaline sulfate users. Check the latest studies of Terbutaline sulfate.

What is Staring?

Staring (a prolonged gaze or fixed look) is found to be associated with 324 drugs and 534 conditions by eHealthMe. Check the latest studies of Staring.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

2,731 people reported to have side effects when taking Terbutaline sulfate.
Among them, 11 people (0.4%) have Staring.

Could Terbutaline sulfate cause Staring?

Among these 11 people:

What is the gender of people who have Staring when taking Terbutaline sulfate? *

  • female: 100 %
  • male: 0.0 %

What are other drugs people take besides Terbutaline sulfate? *

  1. Zithromax: 11 people, 100.00%
  2. Paxil Cr: 11 people, 100.00%
  3. Hydroxyzine Pamoate: 11 people, 100.00%

What are other side effects people have besides Staring? *

  1. Hypotonia (low muscle tone): 11 people, 100.00%
  2. Dysmorphism (difference of body structure that is suggestive of a congenital disorder): 11 people, 100.00%
  3. Joint Range Of Motion Decreased (disease of joint movement): 11 people, 100.00%
  4. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 11 people, 100.00%
  5. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 11 people, 100.00%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 100.00%
  7. Foetal Distress Syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus): 11 people, 100.00%
  8. Feeding Disorder Neonatal (when newborn refuse to drink milk): 11 people, 100.00%
  9. Encephalopathy (functioning of the brain is affected by some agent or condition): 11 people, 100.00%
  10. Dyspnea (difficult or laboured breathing): 11 people, 100.00%

What are the existing conditions these people have? *

  1. Depression: 11 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Terbutaline sulfate and have Staring?

- Check whether Staring is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Terbutaline sulfate:

Staring treatments and more:

How severe was Staring and when was it recovered:

Expand to all the drugs that have ingredients of terbutaline sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Terbutaline sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Staring:

Browse all the conditions that are associated with Staring:


How the study uses the data?

The study uses data from the FDA. It is based on terbutaline sulfate (the active ingredients of Terbutaline sulfate) and Terbutaline sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: